X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Asia

Allergan Expands Dry Eye Portfolio With Launch Of REFRESH OPTIVE® Gel Drops

Yuvraj_pawp by Yuvraj_pawp
24th October 2015
in Asia, News

In a Clinical Study, Patients Report Significant Reduction in Dry Eye Symptoms in Just 30 Days of Usage a leading global pharmaceutical company, today announced the launch of the over-the-counter artificial tear REFRESH OPTIVE® Gel Drops, a new aqueous gel expertly designed for patients who need or desire a more viscous artificial tear option to relieve their Dry Eye symptoms. From REFRESH®, the creators of the number one doctor recommended brand of artificial tears1, new REFRESH OPTIVE® Gel Drops are formulated with Glycerin and a unique blend of the active ingredient CMC which binds to the eye surface to provide long- lasting relief from Dry Eye discomfort.

REFRESH OPTIVE(R) Gel Drops
“With REFRESH OPTIVE® Gel Drops, eye care providers now have an even more comprehensive line of artificial tear types to offer to their patients with individual needs,” said Joseph Vehige, O.D., Vice President of Consumer Eye Care Research & Development, Allergan. “Leveraging the latest technology from OPTIVE®, the new multi-dose Gel Drops help Dry Eye patients find comfort any time, day or night.2″

An estimated 25 million people in the United States suffer from Dry Eye symptoms, including irritation, blurred vision, sensitivity to light, burning, stinging, dryness and excessive tearing.3 In a multicenter, double-masked, randomized study, Dry Eye patients (n=94) using REFRESH OPTIVE® Gel Drops showed a statistically significant reduction in symptoms at day 30.2 The innovative Gel Drops formula delivers a shear-thinning effect that spreads quickly and evenly over the eye surface to relieve Dry Eye symptoms while creating a soothing shield to protect the eye surface from hypertonic stress.

“Dry Eye is a reduction in your eyes’ ability to produce or maintain sufficient quantity and quality of natural tears. Tears are important to the overall health of our eyes and our vision. My patients suffering from Dry Eye symptoms often ask me for a more hydrating artificial tear that will give them longer-lasting relief and comfort,” said Milton M. Hom, OD, FAAO. “I like REFRESH OPTIVE® Gel Drops because of its advanced aqueous gel formulation that helps the ocular surface maintain its moisture level. REFRESH OPTIVE® products are effective in reducing Dry Eye symptoms and convenient to use with no shaking required—just drop and go.”

As the latest addition to REFRESH OPTIVE® product line, REFRESH OPTIVE® Gel Drops are a part of Allergan’s charitable program REFRESH AMERICA to supply America’s heroic first responders with free eye drops. For every purchase of a package in the REFRESH OPTIVE® product line between 8/1/15-7/31/16, Allergan guarantees a minimum product donation with an approximate retail value of $250,000.4 REFRESH OPTIVE® Gel Drops is available in 10 mL multi-dose bottles and can be found nationwide at various retail locations where over-the-counter eye drops are sold.

Tags: Asia Pacific
Previous Post

Allergan Issues Statement On Specialty Pharmacy Utilization

Next Post

Allergan to Present New Data for VIBERZI™ (eluxadoline) at the American College of Gastroenterology 2015 Annual Scientific Meeting

Related Posts

Stringent Policy around COVID Vaccines Laid by FDA
FDA Approvals

Stringent Policy around COVID Vaccines Laid by FDA

29th May 2025
Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
Getty images
Articles

Recombinant DNA Technology Market: A Growth Revolution

19th April 2025
Development Market Growth
Articles

Asia-Pacific Biologics Contract Development Market Growth

19th April 2025
Clinical Development
Articles

AI Revolutionizing Drug Discovery and Clinical Development

19th April 2025
Next Post

Allergan to Present New Data for VIBERZI™ (eluxadoline) at the American College of Gastroenterology 2015 Annual Scientific Meeting

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In